Outcomes of curative surgery and adjuvant radiation therapy in salivary duct carcinoma
Salivary duct cancers, even when treated curatively, have early and distant failures. Over-expression of HER2-neu and AR provide an opportunity to improve the outcomes of curative intent treatment for this cancer with targeted agents and robust data is required to investigate the role of adjuvant endocrine or HER-2 targeted therapies.
Authors
- Divyani Chowdhury
- Paromita Roy (ORCID: https://orcid.org/0000-0003-0379-5999)
- Indu Arun (ORCID: https://orcid.org/0000-0001-6130-6757)
- Pattatheyil Arun (ORCID: https://orcid.org/0000-0002-7828-5777)
- Prateek Jain (ORCID: https://orcid.org/0000-0002-9829-8583)
- Indranil Mallick (ORCID: https://orcid.org/0000-0002-5567-9204)
- Sanjoy Chatterjee (ORCID: https://orcid.org/0000-0001-7402-8645)
- Nivedita Sarkar
- Avinaba Sinha
- Sudipta Pati
- Pasupuleti H. H. M. Sai Hanuman
Institutions
- Tata Medical Center (IN)
Publication Details
- Journal
- Journal of Cancer Research and Therapeutics
- Published
- 2025-04-01
- DOI
- https://doi.org/10.4103/jcrt.jcrt_1842_24
- Primary Topic
- Salivary Gland Tumors Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00